Cargando…
Retracted: FOXD1 Regulates the Sensitivity of Cetuximab by Regulating the Expression of EGFR in Head and Neck Squamous Cell Cancer
Autor principal: | Healthcare Engineering, Journal of |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10396555/ https://www.ncbi.nlm.nih.gov/pubmed/37539336 http://dx.doi.org/10.1155/2023/9818213 |
Ejemplares similares
-
FOXD1 Regulates the Sensitivity of Cetuximab by Regulating the Expression of EGFR in Head and Neck Squamous Cell Cancer
por: Mu, Lan, et al.
Publicado: (2022) -
Retracted: Design and Implementation of Intelligent Monitoring System for Head and Neck Surgery Care Based on Internet of Things (IoT)
por: Healthcare Engineering, Journal of
Publicado: (2023) -
Retracted: Dosimetric Comparison between Volumetric Modulated Arc Therapy (VMAT) and Intensity-Modulated Radiotherapy (IMRT) for Dental Structures of Head and Neck Cancer Patients
por: Healthcare Engineering, Journal of
Publicado: (2022) -
Retracted: SNHG1/miR-145-5p/KLF5 Axis Participates in Regulating the Proliferation and Migration of Oral Squamous Cell Cancer
por: Healthcare Engineering, Journal of
Publicado: (2023) -
Retracted: Research on the Mechanism of HMGB1 Regulating Autoimmune Encephalomyelitis by Regulating NF-κB
por: Healthcare Engineering, Journal of
Publicado: (2023)